Skip to main content
Top
Published in: Diabetologia 3/2005

01-03-2005 | Article

Low birthweight is associated with specific changes in muscle insulin-signalling protein expression

Authors: S. E. Ozanne, C. B. Jensen, K. J. Tingey, H. Storgaard, S. Madsbad, A. A. Vaag

Published in: Diabetologia | Issue 3/2005

Login to get access

Abstract

Aims/hypothesis

People with low birthweight have an increased risk of developing type 2 diabetes mellitus in adulthood. The mechanistic basis of this phenomenon is not known. Here we investigate the effect of early growth restriction on the expression of insulin-signalling proteins in skeletal muscle in a human cohort and a rat model.

Methods

We recruited 20 young men with low birthweight (mean birthweight 2702±202 g) and 20 age-matched control subjects (mean birthweight 3801±99 g). Biopsies were obtained from the vastus lateralis muscle and protein expression of selected insulin-signalling proteins was determined. Rats used for this study were male offspring born to dams fed a standard (20%) protein diet or a low (8%) protein diet during pregnancy and lactation. Protein expression was determined in soleus muscle from adult offspring.

Results

Low-birthweight subjects showed reduced muscle expression of protein kinase C (PKC)ζ, p85α, p110β and GLUT4. PKCζ, GLUT4 and p85 were also reduced in the muscle of rats fed a low-protein diet. Other proteins studied were unchanged in low-birthweight humans and in rats fed a low-protein diet when compared with control groups.

Conclusions/interpretation

We found decreased expression of specific insulin-signalling proteins in low-birthweight subjects compared to controls. These changes precede the onset of impaired glucose tolerance. The similarity of protein expression profile in the men with low birthweight compared to that of the offspring of rats fed a low-protein diet suggests that the rodent model is an accurate representation of the human situation. It also provides a potential mechanistic explanation as to why the fetal environment plays an important role in determining risk of developing type 2 diabetes.
Literature
2.
go back to reference Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S (1998) Mutations in the glucokinase gene of the foetus result in reduced birth weight. Nat Genet 19:268–270CrossRef Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S (1998) Mutations in the glucokinase gene of the foetus result in reduced birth weight. Nat Genet 19:268–270CrossRef
3.
go back to reference Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H (1997) Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446CrossRef Poulsen P, Vaag AA, Kyvik KO, Moller Jensen D, Beck-Nielsen H (1997) Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 40:439–446CrossRef
4.
go back to reference Bo S, Cavallo-Perin P, Scaglione L, Ciccone G, Pagano G (2000) Low birth weight and genetic abnormalities in twins with increased susceptibility to Type 2 diabetes mellitus. Diabet Med 17:365–370CrossRef Bo S, Cavallo-Perin P, Scaglione L, Ciccone G, Pagano G (2000) Low birth weight and genetic abnormalities in twins with increased susceptibility to Type 2 diabetes mellitus. Diabet Med 17:365–370CrossRef
5.
go back to reference Ravelli AC, Van der Meulen JH, Michels RP et al (1998) Glucose intolerance in adults after prenatal exposure to famine. Lancet 351:173–177CrossRef Ravelli AC, Van der Meulen JH, Michels RP et al (1998) Glucose intolerance in adults after prenatal exposure to famine. Lancet 351:173–177CrossRef
6.
go back to reference Hales CN, Ozanne SE (2003) For debate: fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 46:1013–1019CrossRefPubMed Hales CN, Ozanne SE (2003) For debate: fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure. Diabetologia 46:1013–1019CrossRefPubMed
7.
go back to reference Ozanne SE, Olsen GS, Hansen LL et al (2003) Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J Endocrinol 177:235–241CrossRef Ozanne SE, Olsen GS, Hansen LL et al (2003) Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J Endocrinol 177:235–241CrossRef
8.
go back to reference Ozanne SE, Nave BT, Wang CL, Shepherd PR, Prins J, Smith GD (1997) Poor fetal nutrition causes long-term changes in expression of insulin signalling components in adipocytes. Am J Physiol Endocrinol Metab 273:E46–E51 Ozanne SE, Nave BT, Wang CL, Shepherd PR, Prins J, Smith GD (1997) Poor fetal nutrition causes long-term changes in expression of insulin signalling components in adipocytes. Am J Physiol Endocrinol Metab 273:E46–E51
9.
go back to reference Ozanne SE, Dorling MW, Wang CL, Nave BT (2001) Impaired PI 3-kinase activation in adipocytes from early growth-restricted male rats. Am J Physiol Endocrinol Metab 280:E534–E539 Ozanne SE, Dorling MW, Wang CL, Nave BT (2001) Impaired PI 3-kinase activation in adipocytes from early growth-restricted male rats. Am J Physiol Endocrinol Metab 280:E534–E539
10.
go back to reference Farese RV (2002) Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol Endocrinol Metab 283:E1–E11PubMed Farese RV (2002) Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol Endocrinol Metab 283:E1–E11PubMed
12.
go back to reference Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential effects of insulin secretion and action in 19-year-old Caucasian men who had a low birth weight. Diabetes 51:1271–1280 Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA (2002) Early differential effects of insulin secretion and action in 19-year-old Caucasian men who had a low birth weight. Diabetes 51:1271–1280
13.
go back to reference Hermann TS, Rask-Madsen C, Ihlemann N et al (2003) Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birthweight. J Clin Endocrinol Metab 88:1252–1257CrossRef Hermann TS, Rask-Madsen C, Ihlemann N et al (2003) Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birthweight. J Clin Endocrinol Metab 88:1252–1257CrossRef
14.
go back to reference Snoeck A, Remacle C, Reusens B, Hoet JJ (1990) Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 57:107–118 Snoeck A, Remacle C, Reusens B, Hoet JJ (1990) Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 57:107–118
15.
go back to reference Schacterle GR, Pollack RL (1973) A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 51:654–655PubMed Schacterle GR, Pollack RL (1973) A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 51:654–655PubMed
16.
go back to reference Newsome CA, Shiell AW, Fall CH, Phillips DI, Shier R, Law CM (2003) Is birth weight related to later glucose and insulin metabolism?—a systematic review. Diabet Med 20:339–348CrossRef Newsome CA, Shiell AW, Fall CH, Phillips DI, Shier R, Law CM (2003) Is birth weight related to later glucose and insulin metabolism?—a systematic review. Diabet Med 20:339–348CrossRef
17.
go back to reference Krook A, Bjornholm M, Galuska D et al (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49:284–292PubMed Krook A, Bjornholm M, Galuska D et al (2000) Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. Diabetes 49:284–292PubMed
18.
go back to reference Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL (1995) Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle from obese subjects. J Clin Invest 95:2195–2204PubMed Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL (1995) Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle from obese subjects. J Clin Invest 95:2195–2204PubMed
19.
go back to reference Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J (1990) Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:625–627CrossRef Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J (1990) Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:625–627CrossRef
20.
go back to reference Pederson O, Bak JF, Anderson PH et al (1990) Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865–870 Pederson O, Bak JF, Anderson PH et al (1990) Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39:865–870
21.
go back to reference Sinha MK, Raineri-Maldonado C, Buchanan C et al (1991) Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform. Diabetes 40:472–477 Sinha MK, Raineri-Maldonado C, Buchanan C et al (1991) Adipose tissue glucose transporters in NIDDM. Decreased levels of muscle/fat isoform. Diabetes 40:472–477
22.
go back to reference Shepherd PR, Kahn BB (1999). Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. N Engl J Med 341:248–257CrossRef Shepherd PR, Kahn BB (1999). Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. N Engl J Med 341:248–257CrossRef
23.
go back to reference Jaquet D, Vidal H, Hankard P, Czernichow P, Levy-Marchal C (2001) Impaired regulation of glucose transporter 4 gene expression in insulin resistance associated with in utero undernutrition. J Clin Endocrinol Metab 86:3266–3271CrossRef Jaquet D, Vidal H, Hankard P, Czernichow P, Levy-Marchal C (2001) Impaired regulation of glucose transporter 4 gene expression in insulin resistance associated with in utero undernutrition. J Clin Endocrinol Metab 86:3266–3271CrossRef
24.
go back to reference Shepherd PR, Withers DJ, Siddle K (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333:471–490PubMed Shepherd PR, Withers DJ, Siddle K (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333:471–490PubMed
25.
go back to reference Yu J, Zhang Y, Mcllroy J, Rordorf-Nikolic T, Orr GA, Backer JM (1998) Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18:1379–1387 Yu J, Zhang Y, Mcllroy J, Rordorf-Nikolic T, Orr GA, Backer JM (1998) Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18:1379–1387
26.
go back to reference Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR (2002) Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signalling and survival. Mol Cell Biol 22:965–977 Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR (2002) Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signalling and survival. Mol Cell Biol 22:965–977
Metadata
Title
Low birthweight is associated with specific changes in muscle insulin-signalling protein expression
Authors
S. E. Ozanne
C. B. Jensen
K. J. Tingey
H. Storgaard
S. Madsbad
A. A. Vaag
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1669-7

Other articles of this Issue 3/2005

Diabetologia 3/2005 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.